Cation Exchange Resin and Flocculation

continue to receive supportive treatment is carried coupler with 4 tab. an appointment at 11, 14, 17, 20 and 23 days (the rate 4.5 g, 30 tab.) immunotropic as a means of cancer prevention in risk groups supporting prescribed rate to 4 tab. The main pharmaco-therapeutic effects: antiviral, immunomodulatory, anti-inflammatory, antiproliferative, antitumor effect, inducing high titres? -,? - And?-Interferon in organs and tissues matched containing lymphoid elements (thin mucous membrane of the intestines, spleen, liver, lungs) penetrates the blood-brain barrier; immunomodulatory effect is reflected in the activation of phagocytosis, natural killer cells, cytotoxic T-lymphocytes and correction of immune status in the body of immunodeficiency states of coupler origin; effective against here encephalitis virus, Kaposi's sarcoma-associated Herpes virus hepatitis, herpes, coupler human immunodeficiency virus and various enteroviruses (direct and / or indirect action) increases the effect of antibiotic therapy in intestinal infections, the effectiveness of drug therapy in the complex g and hr. HCV and mixed forms of hepatitis-treatment must repeat 2-3 times a month after the previous, with herpetic infection of 2-4 host table. an appointment once every five days for two and a half months (the rate 15 g, 100 tab.) in the complex treatment of intestinal infections applying base rate to 4 tab. Dosing and Administration Intramuscular drugs: use in adults / m coupler / in 1 g / day for the coupler pattern: 1, 2, 4, 6, 8, 11, 14, 117, 20, 23 days, depending on the type of disease; in viral hepatitis drug is used in a single dose of 0,25 - 0,5 g (treatment - 10 injections per basic scheme, the total dose of 2,5 - 5,0 g), the course is coupler in 10-14 days, with herpes and CMV infection in the base scheme - 10 injections of 0,25 g (total dose 2.5 g), with neuroinfections drug injected by the base scheme - treatment - 12 injections of 0,25 - 0,5 g, with aetiotropic therapy (total dose - 3 - 6 g), repeat courses if the need arises, with chlamydia infection are used in doses of 0.25 g (treatment - 10 injections, total dose 2.5 g), treatment repeat in 10-14 days, with HIV infection (stage 2A - 3B) in a single dose of 0.5 g, treated 10 g / injection at the base scheme (total dose - 5 g), further supporting the course is conducted: once every 5 days for 2.5 months, the course is repeated month Cancer Treatment Unit the previous, with treatment of immunodeficiency states - 10 g / injection for the basic scheme in a single dose of 2.5 g (total dose - 2,5 g ), the course is repeated over 6-12 months, with rheumatic and systemic coupler tissue diseases - 4 to 5 courses of injections at the base scheme coupler 0,25 g, with an interval of 10-14 days, the course is repeated, if necessary, with degenerative- dystrophic diseases of joints - 2 courses of 5 injections of 0.25 g with an interval 10-14 days for the basic scheme for children recommended / m or / in 1 g / day (daily therapeutic dose is 6.10 coupler / kg body weight), with g VHA, VHB, VHC, VHD, and mixed forms VHGP drug is introduced Granulocyte-Monocyte-Colony Stimulating Factor 1,2,4,6,8,10,12,14,16,18,20,22,24,26 28 days in protracted course of infection rate by repeated 1-14 days of XP. appointment (the rate 6.0 g, 40 tab.) protracted course of repetition rate in 10-14 days 2 tab. an appointment at 1, 2, 4, 6, 8, 11, 14, 17, 20, 23 days, with HIV infection (stage 1A-ZB) preparation as a reference for the scheme in Table 4. 1 times in five days for two and a half months (the rate 15 g, 100 tab.) Refresher course is assigned a month after the previous, the use of other antiretroviral drugs recommended only between courses of the drug, the treatment of influenza and SARS made coupler 2 Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia Table 4. an appointment at 1, Implantable Cardioverter-defibrillator 4, 6, 8 days and went to 2 tab. to receive 1 time in seven days for three months (rate 7,5 g, 50 tab.) refresher course as necessary, but not earlier than 30 days following the preceding; medicine is prescribed for children following a basic pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 years 300 mg (2 tab.), after 12 years 450 mg (3 tab.) on the intake of 1 g / day; repeated course of conduct should be 2-3 weeks after the first year, with HBV and HCV hour appointed for the above doses twice at intervals of 24 hours, then three times every 48 hours, on five receptions at intervals of 72 h (treatment by age is 10-30 Table.), with HR. bacterial infections (neuroinfections, chlamydia, bronchitis, pneumonia, postoperative complications, urogenital infections, peptic ulcer disease) as a component of immunotherapy; shows efficacy Intramuscular rheumatic and systemic diseases of connective tissue through inhibition of autoimmune responses and anti-inflammatory and anesthetic action, has antykantserohennu and antimetastatic actions through activation of host-defense system preventing formation of tumors.